Cobalt chloride decreases fibroblast growth factor-21 expression dependent on oxidative stress but not hypoxia-inducible factor in Caco-2 cells
Creators
- 1. Department of Medicine, University of Louisville, Louisville, KY (United States)
- 2. School of Pharmacy, Wenzhou Medical College, Wenzhou (China)
- 3. Second Hospital, Jilin University, Changchun (China)
- 4. College of Food Science and Engineering, Jilin Agricultural University, Changchun (China)
- 5. First Hospital, Xi'an Jiaotong University, Xi'an (China)
- 6. Robley Rex Veterans Affairs Medical Center, Louisville, KY (United States)
- 7. Alcohol Research Center, University of Louisville, Louisville, KY (United States)
- 8. Department of Pharmacology and Toxicology, University of Louisville, Louisville, KY (United States)
Description
Fibroblast growth factor-21 (FGF21) is a potential metabolic regulator with multiple beneficial effects on metabolic diseases. FGF21 is mainly expressed in the liver, but is also found in other tissues including the intestine, which expresses β-klotho abundantly. The intestine is a unique organ that operates in a physiologically hypoxic environment, and is responsible for the fat absorption processes including triglyceride breakdown, re-synthesis and absorption into the portal circulation. In the present study, we investigated the effects of hypoxia and the chemical hypoxia inducer, cobalt chloride (CoCl2), on FGF21 expression in Caco-2 cells and the consequence of fat accumulation. Physical hypoxia (1% oxygen) and CoCl2 treatment decreased both FGF21 mRNA and secreted protein levels. Gene silence and inhibition of hypoxia-inducible factor-α (HIFα) did not affect the reduction of FGF21 mRNA and protein levels by hypoxia. However, CoCl2 administration caused a significant increase in oxidative stress. The addition of n-acetylcysteine (NAC) suppressed CoCl2-induced reactive oxygen species (ROS) formation and completely negated CoCl2-induced FGF21 loss. mRNA stability analysis demonstrated that the CoCl2 administration caused a remarkable reduction in FGF21 mRNA stability. Furthermore, CoCl2 increased intracellular triglyceride (TG) accumulation, along with a reduction in mRNA levels of lipid lipase, hormone sensitive lipase (HSL) and adipose triglyceride lipase (ATGL), and an increase of sterol regulatory element-binding protein-1c (SREBP1c) and stearoyl-coenzyme A (SCD1). Addition of both NAC and recombinant FGF21 significantly attenuated the CoCl2-induced TG accumulation. In conclusion, the decrease of FGF21 in Caco-2 cells by chemical hypoxia is independent of HIFα, but dependent on an oxidative stress-mediated mechanism. The regulation of FGF21 by hypoxia may contribute to intestinal lipid metabolism and absorption. -- Graphical abstract: Physical and chemical hypoxia decrease FGF-21 expression, which is inhibited by antioxidant, N-acetyl cysteine (NAC), in Caco-2 cells. Highlights: ► Hypoxia down-regulates FGF21 expression in Caco-2 cells. ► FGF21 down-regulation is HIF-α independent. ► FGF21 down-regulation is modulated by oxidative stress-mediated mRNA stability. ► FGF21 is involved in hypoxia‐induced triglyceride accumulation in Caco-2 cells.
Availability note (English)
Available from http://dx.doi.org/10.1016/j.taap.2012.08.003Additional details
Identifiers
- DOI
- 10.1016/j.taap.2012.08.003;
- PII
- S0041-008X(12)00344-4;
Publishing Information
- Journal Title
- Toxicology and Applied Pharmacology
- Journal Volume
- 264
- Journal Issue
- 2
- Journal Page Range
- p. 212-221
- ISSN
- 0041-008X
- CODEN
- TXAPA9
INIS
- Country of Publication
- United States
- Country of Input or Organization
- International Atomic Energy Agency (IAEA)
- INIS RN
- 45036903
- Subject category
- S60: APPLIED LIFE SCIENCES;
- Descriptors DEI
- ABSORPTION; ANIMAL TISSUES; ANOXIA; ANTIOXIDANTS; BIOLOGICAL STRESS; CELL PROLIFERATION; COBALT CHLORIDES; COENZYMES; CYSTEINE; FATS; FIBROBLASTS; GROWTH FACTORS; HORMONES; INHIBITION; INTESTINES; LIPASES; LIVER; MESSENGER-RNA; METABOLIC DISEASES; OXIDATION; STEROLS; TRIGLYCERIDES
- Descriptors DEC
- AMINO ACIDS; ANIMAL CELLS; BODY; CARBOXYLESTERASES; CARBOXYLIC ACIDS; CHEMICAL REACTIONS; CHLORIDES; CHLORINE COMPOUNDS; COBALT COMPOUNDS; COBALT HALIDES; CONNECTIVE TISSUE CELLS; DIGESTIVE SYSTEM; DISEASES; ENZYMES; ESTERASES; ESTERS; GASTROINTESTINAL TRACT; GLANDS; HALIDES; HALOGEN COMPOUNDS; HYDROLASES; HYDROXY COMPOUNDS; LIPIDS; MITOGENS; NUCLEIC ACIDS; ORGANIC ACIDS; ORGANIC COMPOUNDS; ORGANIC SULFUR COMPOUNDS; ORGANS; PROTEINS; RNA; SOMATIC CELLS; SORPTION; STEROIDS; THIOLS; TRANSITION ELEMENT COMPOUNDS
Optional Information
- Copyright
- Copyright (c) 2012 Elsevier Science B.V., Amsterdam, The Netherlands, All rights reserved.